Literature DB >> 34323226

Contraceptive Technologies: Looking Ahead to New Approaches to Increase Options for Family Planning.

Lisa B Haddad1, John W Townsend, Regine Sitruk-Ware.   

Abstract

With persistently high global rates of unintended pregnancy and contraceptive nonuse, nonadherence and discontinuation, new contraceptive methods must address the needs of women and men who seek alternatives to their current options. Methods under development aim to reduce potential side effects, improve access and ease of use, ensure safety, increase secondary benefits associated with method use and expand options for both women and men. Developmental approaches employed to enhance current methods utilize new delivery systems and novel active pharmaceutical ingredients. This will improve overall user satisfaction with the methods used while expanding the number of options available to provide choice and value user autonomy in the highly diverse contraceptive markets around the world.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34323226      PMCID: PMC8328155          DOI: 10.1097/GRF.0000000000000628

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   1.966


  41 in total

1.  10th Summit Meeting consensus: recommendations for regulatory approval for hormonal male contraception. October 22-23, 2006.

Authors:  Eberhard Nieschlag
Journal:  Contraception       Date:  2007-03       Impact factor: 3.375

2.  Matrix and reservoir-type multipurpose vaginal rings for controlled release of dapivirine and levonorgestrel.

Authors:  Peter Boyd; Susan M Fetherston; Clare F McCoy; Ian Major; Diarmaid J Murphy; Sandeep Kumar; Jonathon Holt; Andrew Brimer; Wendy Blanda; Brid Devlin; R Karl Malcolm
Journal:  Int J Pharm       Date:  2016-07-26       Impact factor: 5.875

Review 3.  New approaches for male fertility control: HE6 as an example of a putative target.

Authors:  Ulrich Gottwald; Ben Davies; Martin Fritsch; Ursula F Habenicht
Journal:  Mol Cell Endocrinol       Date:  2006-01-24       Impact factor: 4.102

4.  A pilot safety and tolerability study of a nonhormonal vaginal contraceptive ring.

Authors:  Giuseppe Del Priore; Jeanetta Malanowska-Stega; Shalaby W Shalaby; Susan Richman
Journal:  J Reprod Med       Date:  2009 Nov-Dec       Impact factor: 0.142

Review 5.  7α-methyl-19-nortestosterone (MENTR): the population council's contribution to research on male contraception and treatment of hypogonadism.

Authors:  Eberhard Nieschlag; Narender Kumar; Régine Sitruk-Ware
Journal:  Contraception       Date:  2012-10-10       Impact factor: 3.375

Review 6.  What some women want? On-demand oral contraception.

Authors:  Elizabeth G Raymond; Tara Shochet; Jennifer Kidwell Drake; Elizabeth Westley
Journal:  Contraception       Date:  2014-04-21       Impact factor: 3.375

7.  Contraceptive technologies for global health: ethically getting to safe, effective and acceptable options for women and men.

Authors:  John Townsend; Régine Sitruk-Ware; Saumya RamaRao; Jim Sailer
Journal:  Drug Deliv Transl Res       Date:  2020-03-02       Impact factor: 4.617

Review 8.  Recent Advances in the Development of In Situ Gelling Drug Delivery Systems for Non-Parenteral Administration Routes.

Authors:  Barbara Vigani; Silvia Rossi; Giuseppina Sandri; Maria Cristina Bonferoni; Carla M Caramella; Franca Ferrari
Journal:  Pharmaceutics       Date:  2020-09-10       Impact factor: 6.321

Review 9.  Male Contraception.

Authors:  Carmen R Abbe; Stephanie T Page; Arthi Thirumalai
Journal:  Yale J Biol Med       Date:  2020-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.